Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled studyBRITISH JOURNAL OF CANCERIF6.82019-08-0613OAAI
Addition of intraperitoneal cisplatin and etoposide to first-line chemotherapy for advanced ovarian cancer: a randomised, phase 2 trialBRITISH JOURNAL OF CANCERIF6.82018-06-149OAAI
未登录.png){kind=icon}
未登录
